Shen Yang Cell Center and Liaoning Zhongzhi Shengjing Geriatrics Hospital concludes a strategic partnership agreement

On March 1, 2019, Shenyang Engineering Technology R&D Center of Cell Therapy and Liaoning Zhongzhi Shengjing Geriatrics Hospital held the signing ceremony for the strategic partnership agreement between the two parties.

 

Q: What fields do SYCC and Liaoning Zhongzhi Shengjing Geriatrics Hospital cooperate in?

A: Shenyang Cell Center and Liaoning Zhongzhi Shengjing Geriatrics Hospital jointly conduct clinical research and application trials on stem cells and immune cells in the treatment of geriatric diseases. Shenyang Cell Center becomes the supplier of cell products for Liaoning Zhongzhi Shengjing Geriatrics Hospital and provides autologous peripheral blood dendritic cells (DC), cytokine-induced killer cells (CIK), allogeneic cord blood CIK cells and mesenchymal stem cells (MSC). The two parties will jointly establish a cell therapy clinical trial and commercialization base, and use their respective expertise to cooperate in the research and application of cell therapy technology.

 

Q: What kind of hospital is Liaoning Zhongzhi Shengjing Geriatrics Hospital?

A: Liaoning Zhongzhi Shengjing Geriatrics Hospital is the first geriatric hospital with high quality standards in Northeast China. It provides a full range of medical services for elderly patients including the early diagnosis, prevention, and treatment of Alzheimer's disease and other diseases, the precision medicine treatment of geriatric diseases, as well as functional rehabilitation.